InMed Pharmaceuticals Inc (INM) Stock Analysis

InMed Pharmaceuticals Inc (INM) is a publicly traded company in the HEALTHCARE sector. It trades at $1.52, carries a market capitalization of $5.20M. This page summarizes the public market data, fundamentals, and frequently asked questions for INM, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

Market Sentiment

InMed Pharmaceuticals Inc currently has a Neutral sentiment score of -0.07.

About InMed Pharmaceuticals Inc

InMed Pharmaceuticals Inc. is a clinical-stage biopharmaceutical firm headquartered in Vancouver, Canada, dedicated to the discovery and development of innovative cannabinoid-based therapies for a range of medical conditions. Utilizing its proprietary biosynthesis technology, InMed is committed to producing pharmaceutical-grade cannabinoids aimed at addressing significant unmet medical needs. With a well-defined pipeline of drug candidates advancing through clinical trials, the company is str...

GNG Research Analysis

GNG Research scores InMed Pharmaceuticals Inc (INM) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for INM.

Frequently Asked Questions

Does INM pay dividends?

InMed Pharmaceuticals Inc (INM) does not currently pay a regular dividend.

What is INM's market cap?

InMed Pharmaceuticals Inc (INM) has a market capitalization of $5.20M with a current stock price of $1.52.